Luteolin-7-O-glucoside from Elsholtzia ciliata extract inhibits the replication of coronavirus
PLOS One · 03.06.2025 · 20 (6) · e0325371
DOI: 10.1371/journal.pone.0325371 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 03.06.2025. Verfasst von Siyun Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biological Science and Technology, Yonsei University, Wonju, Republic of Korea. Hauptthemen laut MEDLINE: Virus Replication, Plant Extracts, Glucosides, Antiviral Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rural Development Administration.
Abstract (Originalsprache)
Coronaviruses are RNA viruses with a high mutation rate that cause many human diseases, from severe COVID-19 to mild common cold. Therefore, discovering various medicines is required to reduce the symptoms of coronavirus infection. This report showed that the ethanol extract of the aerial parts of Elsholtzia ciliata (ECE) and its constituents can inhibit HCoV-OC43 (Human Coronavirus OC43) replication. HCoV-OC43, a human betacoronavirus genetically related to SARS-CoV-2, was used as a surrogate virus under BSL-2 conditions. To evaluate the antiviral properties of ECE, viral RNA levels were quantified using qRT-PCR, and viral protein expression was analyzed through Western blotting. ECE reduced coronavirus-induced plaque formation and viral RNA and protein expression in coronavirus-infected cells and conditioned media. Additionally, this was confirmed to have an inhibitory activity on virus production and improved cytopathic effects. ECE showed no cytotoxicity up to 40 µg/mL in vitro. As Elsholtzia ciliata has traditionally been consumed as a tea, oral administration could be a suitable route for further in vivo investigation. The main components of ECE were revealed by HPLC analysis and were isolated into four single compounds 1 – 4 . Among them, luteolin-7- O -glucoside was effective in inhibiting the replication of coronavirus. Luteolin-7-O-glucoside demonstrated greater antiviral activity than ECE, with an estimated IC 50 of 2 µM (around 1 µg/mL) compared to 5 µg/mL for ECE. This finding suggests that luteolin-7-O-glucoside could be a key contributor to the antiviral activity of the ECE. Finally, these results collectively suggest that Elsholtzia ciliata can be used as a potential antiviral treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Biological Science and Technology, Yonsei University, Wonju, Republic of Korea.
- Department of Herbal Crop Research, National Institute of Horticultural & Herbal Science, RDA, Eumsung, Republic of Korea.
- R&D team, Korea Mine Rehabilitation and Mineral Resources Corporation, Wonju, Korea.
ORCID-Profile: Junsoo Park
Förderung
- Rural Development Administration
Zitieren
APA
Lee, S., Kim, J. H., Kim, C., Jung, W., Park, J., & Park, J. (2025). Luteolin-7-O-glucoside from Elsholtzia ciliata extract inhibits the replication of coronavirus. PLOS One, 20(6), e0325371. https://doi.org/10.1371/journal.pone.0325371
Vancouver
Lee S, Kim JH, Kim C, Jung W, Park J, Park J. Luteolin-7-O-glucoside from Elsholtzia ciliata extract inhibits the replication of coronavirus. PLOS One. 2025;20(6):e0325371. doi:10.1371/journal.pone.0325371
BibTeX
@article{Lee2025,
author = {Lee, Siyun and Kim, Jang Hoon and Kim, Chansoo and Jung, Woochul and Park, Jayhyun and Park, Junsoo},
title = {Luteolin-7-O-glucoside from Elsholtzia ciliata extract inhibits the replication of coronavirus},
journal = {PLOS One},
year = {2025},
volume = {20},
number = {6},
pages = {e0325371},
doi = {10.1371/journal.pone.0325371}
}
EUVIMED